Clinical Trial Update: Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B [Phase 4]

View source ↗

Summary

Phase 4 trial assessing long-term persistence of immunity to hepatitis B in adults vaccinated with Engerix-B (HBV) by GSK; results posted in 2018. No disease-sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B Vaccine | Phase 4 | Status: COMPLETED | Results posted: 2018-08-03